<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>CLL CAST</title>
    <link>http://www.lls.org</link>
    <description>Podcast for those living with Chronic Lymphocytic Leukemia (CLL). Sponsored by The Leukemia &amp; Lymphoma Society</description>
    <copyright>(c)2008</copyright>
    <managingEditor>admin@lls.org (admin@lls.org)</managingEditor>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 May 2013 17:22:14 GMT</lastBuildDate>
    <generator>Hipcast RSS Feeder 1.25</generator>
    <category>Health &amp; Fitness</category>
    <atom:link href="http://lls.hipcast.com/rss/cllcast.xml" rel="self" type="application/rss+xml"/>
    <ttl>60</ttl>
    <image>
      <url>http://lls.hipcast.com/albumart/1010.1369243334.jpg</url>
      <link>http://www.lls.org</link>
      <title>CLL CAST</title>
    </image>
    <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
    <itunes:summary>Podcast for those living with Chronic Lymphocytic Leukemia (CLL). Sponsored by The Leukemia &amp; Lymphoma Society</itunes:summary>
    <itunes:subtitle></itunes:subtitle>
    <itunes:explicit>no</itunes:explicit>
    <itunes:keywords>cll,chronic,lymphocytic,leukemia,cancer</itunes:keywords>
    <itunes:owner>
      <itunes:name>Samantha Mills</itunes:name>
      <itunes:email>admin@leukemia-lymphoma.org</itunes:email>
    </itunes:owner>
    <itunes:image href="http://lls.hipcast.com/albumart/1010.1369243334.jpg"/>
    <itunes:category text="Health"/>
    <itunes:category text="Science &amp; Medicine">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">89ee171b-b5b9-efe1-7f1c-ce2c08e9b663</guid>
      <title>Update on CLL - Part 2</title>
      <description><![CDATA[Date: May 1, 2013
Speaker: John C. Byrd, MD

Topics Covered:
CLL signs and symptoms
Tests used to diagnose and stage CLL
Current and emerging treatments for CLL patients
Personalized CLL treatment plans
Importance of clinical trials to improve CLL patient outcomes
CLL side effects management and quality of life]]></description>
      <pubDate>Fri, 17 May 2013 14:35:01 GMT</pubDate>
      <itunes:duration>00:26:41</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: May 1, 2013&#13;
Speaker: John C. Byrd, MD&#13;
&#13;
Topics Covered:&#13;
CLL signs and symptoms&#13;
Tests used to diagnose and stage CLL&#13;
Current and emerging treatments for CLL patients&#13;
Personalized CLL treatment plans&#13;
Importance of clinical trials to improve CLL patient outcomes&#13;
CLL side effects management and quality of life</itunes:summary>
      <itunes:subtitle>Update on CLL - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/d21b3b71-a6b0-25cc-114d-ca3fd34698d6.mp3" type="audio/mpeg" length="6403681"/>
      <media:title>Update on CLL - Part 2</media:title>
      <media:text type="plain">Date: May 1, 2013&#13;
Speaker: John C. Byrd, MD&#13;
&#13;
Topics Covered:&#13;
CLL signs and symptoms&#13;
Tests used to diagnose and stage CLL&#13;
Current and emerging treatments for CLL patients&#13;
Personalized CLL treatment plans&#13;
Importance of clinical trials to improve CLL patient outcomes&#13;
CLL side effects management and quality of life</media:text>
      <media:content url="http://lls.hipcast.com/deluge/d21b3b71-a6b0-25cc-114d-ca3fd34698d6.mp3" type="audio/mpeg" fileSize="6403681" duration="1601"/>
      <link>http://lls.hipcast.com/deluge/d21b3b71-a6b0-25cc-114d-ca3fd34698d6.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">0b0ad31a-830b-71a4-ced4-fc889a6385be</guid>
      <title>Update on CLL - Part 1</title>
      <description><![CDATA[Date: May 1, 2013
Speaker: John C. Byrd, MD

Topics Covered:
CLL signs and symptoms
Tests used to diagnose and stage CLL
Current and emerging treatments for CLL patients
Personalized CLL treatment plans
Importance of clinical trials to improve CLL patient outcomes
CLL side effects management and quality of life]]></description>
      <pubDate>Fri, 17 May 2013 14:33:54 GMT</pubDate>
      <itunes:duration>00:32:05</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: May 1, 2013&#13;
Speaker: John C. Byrd, MD&#13;
&#13;
Topics Covered:&#13;
CLL signs and symptoms&#13;
Tests used to diagnose and stage CLL&#13;
Current and emerging treatments for CLL patients&#13;
Personalized CLL treatment plans&#13;
Importance of clinical trials to improve CLL patient outcomes&#13;
CLL side effects management and quality of life</itunes:summary>
      <itunes:subtitle>Update on CLL - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/cb1e9efc-03a5-01e7-f6a0-3fa5f0071d5c.mp3" type="audio/mpeg" length="7704887"/>
      <media:title>Update on CLL - Part 1</media:title>
      <media:text type="plain">Date: May 1, 2013&#13;
Speaker: John C. Byrd, MD&#13;
&#13;
Topics Covered:&#13;
CLL signs and symptoms&#13;
Tests used to diagnose and stage CLL&#13;
Current and emerging treatments for CLL patients&#13;
Personalized CLL treatment plans&#13;
Importance of clinical trials to improve CLL patient outcomes&#13;
CLL side effects management and quality of life</media:text>
      <media:content url="http://lls.hipcast.com/deluge/cb1e9efc-03a5-01e7-f6a0-3fa5f0071d5c.mp3" type="audio/mpeg" fileSize="7704887" duration="1925"/>
      <link>http://lls.hipcast.com/deluge/cb1e9efc-03a5-01e7-f6a0-3fa5f0071d5c.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">69c169b3-56fd-4524-d950-d16e0a2871e7</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 1</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:
Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:24:56 GMT</pubDate>
      <itunes:duration>00:40:24</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" length="9697545"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 1</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3" type="audio/mpeg" fileSize="9697545" duration="2424"/>
      <link>http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">b5f8af4a-bdf1-6841-b0aa-8b89b668b184</guid>
      <title>Blood Cancer Treatment - Making Informed Choices - Part 2</title>
      <description><![CDATA[Date: February 26, 2013

Speaker: Stephen D. Nimer, MD

Topics:

Understanding goals of treatment for your diagnosis
Understanding your treatment options
Benefits and risks for standard treatments and investigational treatments
Key facts about clinical trials]]></description>
      <pubDate>Fri, 05 Apr 2013 20:24:27 GMT</pubDate>
      <itunes:duration>00:14:31</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</itunes:summary>
      <itunes:subtitle>Blood Cancer Treatment - Making Informed Choices - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" length="3485940"/>
      <media:title>Blood Cancer Treatment - Making Informed Choices - Part 2</media:title>
      <media:text type="plain">Date: February 26, 2013&#13;
&#13;
Speaker: Stephen D. Nimer, MD&#13;
&#13;
Topics:&#13;
&#13;
Understanding goals of treatment for your diagnosis&#13;
Understanding your treatment options&#13;
Benefits and risks for standard treatments and investigational treatments&#13;
Key facts about clinical trials</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3" type="audio/mpeg" fileSize="3485940" duration="871"/>
      <link>http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">8356dff9-0765-c62e-f0de-8c6be09b355d</guid>
      <title>CLL- Understanding Diagnosis and Treatment Part 2</title>
      <description><![CDATA[Speaker: Michael J. Keating, MB, BS; Topics: - Tests used to diagnose
and stage CLL; - Current and emerging treatments for CLL patients; -
Personalized CLL treatment plans; - Importance of clinical trials in
improving CLL patient outcomes; - CLL side effects management and
quality of life]]></description>
      <pubDate>Thu, 29 Mar 2012 12:09:41 GMT</pubDate>
      <itunes:duration>00:25:19</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Michael J. Keating, MB, BS; Topics: - Tests used to diagnose&#13;
and stage CLL; - Current and emerging treatments for CLL patients; -&#13;
Personalized CLL treatment plans; - Importance of clinical trials in&#13;
improving CLL patient outcomes; - CLL side effects management and&#13;
quality of life</itunes:summary>
      <itunes:subtitle>CLL- Understanding Diagnosis and Treatment Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2ae01141-71ae-12a7-3c5b-e6406350542e.mp3" type="audio/mpeg" length="24296930"/>
      <media:title>CLL- Understanding Diagnosis and Treatment Part 2</media:title>
      <media:text type="plain">Speaker: Michael J. Keating, MB, BS; Topics: - Tests used to diagnose&#13;
and stage CLL; - Current and emerging treatments for CLL patients; -&#13;
Personalized CLL treatment plans; - Importance of clinical trials in&#13;
improving CLL patient outcomes; - CLL side effects management and&#13;
quality of life</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2ae01141-71ae-12a7-3c5b-e6406350542e.mp3" type="audio/mpeg" fileSize="24296930" duration="1519"/>
      <link>http://lls.hipcast.com/deluge/2ae01141-71ae-12a7-3c5b-e6406350542e.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">04125188-cc1f-e345-7d4c-9f86df3bcf72</guid>
      <title>CLL- Understanding Diagnosis and Treatment Part 1</title>
      <description><![CDATA[Speaker: Michael J. Keating, MB, BS; Topics: - Tests used to diagnose and stage CLL; - Current and emerging treatments for CLL patients; - Personalized CLL treatment plans; - Importance of clinical trials in improving CLL patient outcomes; - CLL side effects management and quality of life]]></description>
      <pubDate>Fri, 23 Mar 2012 17:04:37 GMT</pubDate>
      <itunes:duration>00:33:21</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Speaker: Michael J. Keating, MB, BS; Topics: - Tests used to diagnose and stage CLL; - Current and emerging treatments for CLL patients; - Personalized CLL treatment plans; - Importance of clinical trials in improving CLL patient outcomes; - CLL side effects management and quality of life</itunes:summary>
      <itunes:subtitle>CLL- Understanding Diagnosis and Treatment Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c6c7758a-0218-2652-6fcc-ed5d408948f4.mp3" type="audio/mpeg" length="16009635"/>
      <media:title>CLL- Understanding Diagnosis and Treatment Part 1</media:title>
      <media:text type="plain">Speaker: Michael J. Keating, MB, BS; Topics: - Tests used to diagnose and stage CLL; - Current and emerging treatments for CLL patients; - Personalized CLL treatment plans; - Importance of clinical trials in improving CLL patient outcomes; - CLL side effects management and quality of life</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c6c7758a-0218-2652-6fcc-ed5d408948f4.mp3" type="audio/mpeg" fileSize="16009635" duration="2001"/>
      <link>http://lls.hipcast.com/deluge/c6c7758a-0218-2652-6fcc-ed5d408948f4.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">845a5221-550b-49a5-5908-7d3a4baee24b</guid>
      <title>CLL Update - Emerging Therapies - Part II Spanish</title>
      <description><![CDATA[June 21, 2011 - Part II Spanish - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.]]></description>
      <pubDate>Fri, 19 Aug 2011 13:08:40 GMT</pubDate>
      <itunes:duration>00:28:21</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 21, 2011 - Part II Spanish - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</itunes:summary>
      <itunes:subtitle>CLL Update - Emerging Therapies - Part II Spanish</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ac5885fb-6455-589b-2b58-e3b050247ee3.mp3" type="audio/mpeg" length="6804608"/>
      <media:title>CLL Update - Emerging Therapies - Part II Spanish</media:title>
      <media:text type="plain">June 21, 2011 - Part II Spanish - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ac5885fb-6455-589b-2b58-e3b050247ee3.mp3" type="audio/mpeg" fileSize="6804608" duration="1701"/>
      <link>http://lls.hipcast.com/deluge/ac5885fb-6455-589b-2b58-e3b050247ee3.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">6241899b-1aab-c41f-d5e8-cbed6ae8c315</guid>
      <title>CLL Update - Emerging Therapies - Part I Spanish</title>
      <description><![CDATA[June 21, 2011 - Part I Spanish - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.]]></description>
      <pubDate>Fri, 19 Aug 2011 13:08:25 GMT</pubDate>
      <itunes:duration>00:35:04</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 21, 2011 - Part I Spanish - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</itunes:summary>
      <itunes:subtitle>CLL Update - Emerging Therapies - Part I Spanish</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/803f01b8-9016-d3b8-f303-d964a2312ed0.mp3" type="audio/mpeg" length="8414482"/>
      <media:title>CLL Update - Emerging Therapies - Part I Spanish</media:title>
      <media:text type="plain">June 21, 2011 - Part I Spanish - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/803f01b8-9016-d3b8-f303-d964a2312ed0.mp3" type="audio/mpeg" fileSize="8414482" duration="2104"/>
      <link>http://lls.hipcast.com/deluge/803f01b8-9016-d3b8-f303-d964a2312ed0.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">f0bf351e-d8df-bfe3-b5d9-0c37b5b55741</guid>
      <title>CLL Update - Emerging Therapies - Part II</title>
      <description><![CDATA[June 21, 2011 - Part II - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.]]></description>
      <pubDate>Fri, 19 Aug 2011 13:08:03 GMT</pubDate>
      <itunes:duration>00:25:25</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 21, 2011 - Part II - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</itunes:summary>
      <itunes:subtitle>CLL Update - Emerging Therapies - Part II</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/f0c34ea1-dddb-c76a-0303-b70bbc169f5d.mp3" type="audio/mpeg" length="6101914"/>
      <media:title>CLL Update - Emerging Therapies - Part II</media:title>
      <media:text type="plain">June 21, 2011 - Part II - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/f0c34ea1-dddb-c76a-0303-b70bbc169f5d.mp3" type="audio/mpeg" fileSize="6101914" duration="1525"/>
      <link>http://lls.hipcast.com/deluge/f0c34ea1-dddb-c76a-0303-b70bbc169f5d.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">d8ea5561-5441-a082-a95e-53529f76fa20</guid>
      <title>CLL Update - Emerging Therapies - Part I</title>
      <description><![CDATA[June 21, 2011 - Part I - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.]]></description>
      <pubDate>Fri, 19 Aug 2011 13:07:36 GMT</pubDate>
      <itunes:duration>00:34:36</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 21, 2011 - Part I - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</itunes:summary>
      <itunes:subtitle>CLL Update - Emerging Therapies - Part I</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/76f081c9-a209-8f6e-1eac-868a0d67a627.mp3" type="audio/mpeg" length="8304246"/>
      <media:title>CLL Update - Emerging Therapies - Part I</media:title>
      <media:text type="plain">June 21, 2011 - Part I - Dr. O'Brien discusses the newest drug and treatment options as well as new opportunities unfolding to treat CLL patients. Dr. O'Brien answers audience questions during the interactive segment of the program.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/76f081c9-a209-8f6e-1eac-868a0d67a627.mp3" type="audio/mpeg" fileSize="8304246" duration="2076"/>
      <link>http://lls.hipcast.com/deluge/76f081c9-a209-8f6e-1eac-868a0d67a627.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">2436c6e3-ffed-d161-9fe8-43af4d2eec19</guid>
      <title>CLL: What's New from the ASH Annual Meeting - Part 2</title>
      <description><![CDATA[December 15, 2010 - Part 2 (Q&A)

CLL: What's New from the American Society of Hematology (ASH) Annual Meeting

This program featured John C. Byrd, MD,  D. Warren Brown Professor of Leukemia Research, Director, Division of Hematology, Department of Internal Medicine, Associate Director for Translational Research, Professor of Medicine and Medicinal Chemistry, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.

This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Sanofi-Aventis and Cephalon Oncology.

Program Slides: http://www.lls.org/graphics/National/CLL12.15SlidesDr.Byrd.pdf]]></description>
      <pubDate>Tue, 25 Jan 2011 18:31:04 GMT</pubDate>
      <itunes:duration>00:10:54</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>December 15, 2010 - Part 2 (Q&amp;A)&#13;
&#13;
CLL: What's New from the American Society of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured John C. Byrd, MD,  D. Warren Brown Professor of Leukemia Research, Director, Division of Hematology, Department of Internal Medicine, Associate Director for Translational Research, Professor of Medicine and Medicinal Chemistry, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Sanofi-Aventis and Cephalon Oncology.&#13;
&#13;
Program Slides: http://www.lls.org/graphics/National/CLL12.15SlidesDr.Byrd.pdf</itunes:summary>
      <itunes:subtitle>CLL: What's New from the ASH Annual Meeting - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c9cc10a0-a362-35f1-dcdf-38796cdaeb24.mp3" type="audio/mpeg" length="2614776"/>
      <media:title>CLL: What's New from the ASH Annual Meeting - Part 2</media:title>
      <media:text type="plain">December 15, 2010 - Part 2 (Q&amp;A)&#13;
&#13;
CLL: What's New from the American Society of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured John C. Byrd, MD,  D. Warren Brown Professor of Leukemia Research, Director, Division of Hematology, Department of Internal Medicine, Associate Director for Translational Research, Professor of Medicine and Medicinal Chemistry, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Sanofi-Aventis and Cephalon Oncology.&#13;
&#13;
Program Slides: http://www.lls.org/graphics/National/CLL12.15SlidesDr.Byrd.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c9cc10a0-a362-35f1-dcdf-38796cdaeb24.mp3" type="audio/mpeg" fileSize="2614776" duration="654"/>
      <link>http://lls.hipcast.com/deluge/c9cc10a0-a362-35f1-dcdf-38796cdaeb24.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">697bcaed-4c6f-b77b-4542-6948f06e391d</guid>
      <title>CLL: What's New from the ASH Annual Meeting - Part 1</title>
      <description><![CDATA[December 15, 2010 - Part 1 (Presentation)

CLL: What's New from the American Society of Hematology (ASH) Annual Meeting

This program featured John C. Byrd, MD,  D. Warren Brown Professor of Leukemia Research, Director, Division of Hematology, Department of Internal Medicine, Associate Director for Translational Research, Professor of Medicine and Medicinal Chemistry, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.

This program was sponsored by The Leukemia & Lymphoma Society and supported by grants from Sanofi-Aventis and Cephalon Oncology.

Program Slides: http://www.lls.org/graphics/National/CLL12.15SlidesDr.Byrd.pdf]]></description>
      <pubDate>Tue, 25 Jan 2011 18:30:08 GMT</pubDate>
      <itunes:duration>00:38:41</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>December 15, 2010 - Part 1 (Presentation)&#13;
&#13;
CLL: What's New from the American Society of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured John C. Byrd, MD,  D. Warren Brown Professor of Leukemia Research, Director, Division of Hematology, Department of Internal Medicine, Associate Director for Translational Research, Professor of Medicine and Medicinal Chemistry, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Sanofi-Aventis and Cephalon Oncology.&#13;
&#13;
Program Slides: http://www.lls.org/graphics/National/CLL12.15SlidesDr.Byrd.pdf</itunes:summary>
      <itunes:subtitle>CLL: What's New from the ASH Annual Meeting - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6af4224c-e89b-cfdd-c6cb-a21e018e28d0.mp3" type="audio/mpeg" length="9282897"/>
      <media:title>CLL: What's New from the ASH Annual Meeting - Part 1</media:title>
      <media:text type="plain">December 15, 2010 - Part 1 (Presentation)&#13;
&#13;
CLL: What's New from the American Society of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured John C. Byrd, MD,  D. Warren Brown Professor of Leukemia Research, Director, Division of Hematology, Department of Internal Medicine, Associate Director for Translational Research, Professor of Medicine and Medicinal Chemistry, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by grants from Sanofi-Aventis and Cephalon Oncology.&#13;
&#13;
Program Slides: http://www.lls.org/graphics/National/CLL12.15SlidesDr.Byrd.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6af4224c-e89b-cfdd-c6cb-a21e018e28d0.mp3" type="audio/mpeg" fileSize="9282897" duration="2321"/>
      <link>http://lls.hipcast.com/deluge/6af4224c-e89b-cfdd-c6cb-a21e018e28d0.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">a170df26-5bb3-086a-fbaa-bb49ad3b2c3a</guid>
      <title>Getting the Answers You Need: Fatigue and Other Cancer Treatment</title>
      <description><![CDATA[Getting the Answers You Need: Fatigue and Other Cancer Treatment
October 20, 2010

This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society.

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec.

Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf]]></description>
      <pubDate>Wed, 03 Nov 2010 19:25:12 GMT</pubDate>
      <itunes:duration>00:56:55</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>Getting the Answers You Need: Fatigue and Other Cancer Treatment&#13;
October 20, 2010&#13;
&#13;
This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf</itunes:summary>
      <itunes:subtitle>Getting the Answers You Need: Fatigue and Other Cancer Treatment</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3" type="audio/mpeg" length="13659975"/>
      <media:title>Getting the Answers You Need: Fatigue and Other Cancer Treatment</media:title>
      <media:text type="plain">Getting the Answers You Need: Fatigue and Other Cancer Treatment&#13;
October 20, 2010&#13;
&#13;
This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf</media:text>
      <media:content url="http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3" type="audio/mpeg" fileSize="13659975" duration="3415"/>
      <link>http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">3b7be349-28a8-dfcd-fde0-ce1a0b5e21d6</guid>
      <title>Navigating Employment and Insurance</title>
      <description><![CDATA[June 30, 2010

Navigating Employment and Insurance

This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society.

This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec.

Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt]]></description>
      <pubDate>Fri, 16 Jul 2010 18:23:06 GMT</pubDate>
      <itunes:duration>00:51:40</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 30, 2010&#13;
&#13;
Navigating Employment and Insurance&#13;
&#13;
This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt</itunes:summary>
      <itunes:subtitle>A Young Adult Webcast</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3" type="audio/mpeg" length="12399096"/>
      <media:title>Navigating Employment and Insurance</media:title>
      <media:text type="plain">June 30, 2010&#13;
&#13;
Navigating Employment and Insurance&#13;
&#13;
This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia &amp; Lymphoma Society.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by a grant from Genentech and Biogen Idec.&#13;
&#13;
Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt</media:text>
      <media:content url="http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3" type="audio/mpeg" fileSize="12399096" duration="3100"/>
      <link>http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">34088971-d838-512c-08b1-c5f6dc216cce</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 2</title>
      <description><![CDATA[June 22, 2010 - Part 2

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:13:58 GMT</pubDate>
      <itunes:duration>00:59:54</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" length="14377715"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 2</media:title>
      <media:text type="plain">June 22, 2010 - Part 2&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3" type="audio/mpeg" fileSize="14377715" duration="3594"/>
      <link>http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">43594e91-1acc-fb9e-62ed-f9229723e170</guid>
      <title>Partners in Progress: An Expert Panel Discussion - Part 1</title>
      <description><![CDATA[June 22, 2010 - Part 1

Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers

This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.
 
This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.]]></description>
      <pubDate>Fri, 09 Jul 2010 16:12:44 GMT</pubDate>
      <itunes:duration>00:53:18</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</itunes:summary>
      <itunes:subtitle>Partners in Progress: An Expert Panel Discussion - Part 1</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" length="12792605"/>
      <media:title>Partners in Progress: An Expert Panel Discussion - Part 1</media:title>
      <media:text type="plain">June 22, 2010 - Part 1&#13;
&#13;
Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers&#13;
&#13;
This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine &amp; Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia &amp; Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.&#13;
 &#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3" type="audio/mpeg" fileSize="12792605" duration="3198"/>
      <link>http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">b960dda2-b724-df79-3258-ddb742294b68</guid>
      <title>New Developments in CLL from ASH Annual Meeting</title>
      <description><![CDATA[December 10, 2009

New Developments in CLL from the American Society Of Hematology (ASH) Annual Meeting

This program featured Susan O'Brien, MD, Professor of Medicine, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Cephalon Oncology.]]></description>
      <pubDate>Thu, 17 Dec 2009 15:51:01 GMT</pubDate>
      <itunes:duration>00:56:12</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>December 10, 2009&#13;
&#13;
New Developments in CLL from the American Society Of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured Susan O'Brien, MD, Professor of Medicine, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Cephalon Oncology.</itunes:summary>
      <itunes:subtitle>New Developments in CLL from ASH Annual Meeting</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/4864f43c-9d75-cdae-1af6-9263cbc11c6f.mp3" type="audio/mpeg" length="13490074"/>
      <media:title>New Developments in CLL from ASH Annual Meeting</media:title>
      <media:text type="plain">December 10, 2009&#13;
&#13;
New Developments in CLL from the American Society Of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured Susan O'Brien, MD, Professor of Medicine, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by a grant from Cephalon Oncology.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/4864f43c-9d75-cdae-1af6-9263cbc11c6f.mp3" type="audio/mpeg" fileSize="13490074" duration="3372"/>
      <link>http://lls.hipcast.com/deluge/4864f43c-9d75-cdae-1af6-9263cbc11c6f.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">5cba86a6-d6d0-3fdb-554e-7706bb39dcb7</guid>
      <title>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma</title>
      <description><![CDATA[June 16, 2009

This program featured Gail J. Roboz, MD, Associate Professor of Medicine, Director, Leukemia Program, Weill Medical College of Cornell University/New York-Presbyterian Hospital, New York, NY and John P. Leonard, MD, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Medical College of Cornell University/New York-Presbyterian Hospital, Clinical Director, New York - Cornell Center for Lymphoma and Myeloma, New York, NY and Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX.

This program was supported in part by Celgene.]]></description>
      <pubDate>Fri, 19 Jun 2009 15:11:22 GMT</pubDate>
      <itunes:duration>01:28:06</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>June 16, 2009&#13;
&#13;
This program featured Gail J. Roboz, MD, Associate Professor of Medicine, Director, Leukemia Program, Weill Medical College of Cornell University/New York-Presbyterian Hospital, New York, NY and John P. Leonard, MD, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Medical College of Cornell University/New York-Presbyterian Hospital, Clinical Director, New York - Cornell Center for Lymphoma and Myeloma, New York, NY and Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was supported in part by Celgene.</itunes:summary>
      <itunes:subtitle>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/4f31d558-f1fd-71d6-8dd3-78a10824d6e8.mp3" type="audio/mpeg" length="21142593"/>
      <media:title>Emerging Therapies in Leukemia, Lymphoma &amp; Myeloma</media:title>
      <media:text type="plain">June 16, 2009&#13;
&#13;
This program featured Gail J. Roboz, MD, Associate Professor of Medicine, Director, Leukemia Program, Weill Medical College of Cornell University/New York-Presbyterian Hospital, New York, NY and John P. Leonard, MD, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Medical College of Cornell University/New York-Presbyterian Hospital, Clinical Director, New York - Cornell Center for Lymphoma and Myeloma, New York, NY and Robert Z. Orlowski, MD, PhD, Director, Myeloma Section, Associate Professor, Departments of Lymphoma/Myeloma and Experimental Therapeutics, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was supported in part by Celgene.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/4f31d558-f1fd-71d6-8dd3-78a10824d6e8.mp3" type="audio/mpeg" fileSize="21142593" duration="5286"/>
      <link>http://lls.hipcast.com/deluge/4f31d558-f1fd-71d6-8dd3-78a10824d6e8.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">2e3eb6d4-dbd1-4147-da7a-a71be38575fe</guid>
      <title>CLL: Update from the ASH Annual Meeting</title>
      <description><![CDATA[12/16/2008

CLL: Update from the American Society of Hematology (ASH) Annual Meeting

This program featured Michael J. Keating, MB, BS, Professor of Medicine, Department of Hematology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by an unrestricted grant from Cephalon Oncology and Biogen Idec Oncology.]]></description>
      <pubDate>Thu, 22 Jan 2009 16:33:16 GMT</pubDate>
      <itunes:duration>00:48:57</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>12/16/2008&#13;
&#13;
CLL: Update from the American Society of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured Michael J. Keating, MB, BS, Professor of Medicine, Department of Hematology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted grant from Cephalon Oncology and Biogen Idec Oncology.</itunes:summary>
      <itunes:subtitle>CLL: Update from the ASH Annual Meeting</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/18a1e659-da7e-e609-00ef-4a0422ef84bb.mp3" type="audio/mpeg" length="11748543"/>
      <media:title>CLL: Update from the ASH Annual Meeting</media:title>
      <media:text type="plain">12/16/2008&#13;
&#13;
CLL: Update from the American Society of Hematology (ASH) Annual Meeting&#13;
&#13;
This program featured Michael J. Keating, MB, BS, Professor of Medicine, Department of Hematology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted grant from Cephalon Oncology and Biogen Idec Oncology.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/18a1e659-da7e-e609-00ef-4a0422ef84bb.mp3" type="audio/mpeg" fileSize="11748543" duration="2937"/>
      <link>http://lls.hipcast.com/deluge/18a1e659-da7e-e609-00ef-4a0422ef84bb.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">527aa2ce-648a-f4dd-c675-a69e79c8c823</guid>
      <title>CLL Therapy: An Update from ASCO</title>
      <description><![CDATA[6/25/2008

CLL Therapy: An Update from the American Society of Clinical Oncology

This program featured Thomas J. Kipps, M.D., PhD, professor, Department of Medicine, Deputy Director of Research, Moores University of California, San Diego (UCSD) Cancer Center, San Diego, CA.

This program was sponsored by The Leukemia & Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Biogen Idec.]]></description>
      <pubDate>Fri, 11 Jul 2008 16:45:54 GMT</pubDate>
      <itunes:duration>01:01:10</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>6/25/2008&#13;
&#13;
CLL Therapy: An Update from the American Society of Clinical Oncology&#13;
&#13;
This program featured Thomas J. Kipps, M.D., PhD, professor, Department of Medicine, Deputy Director of Research, Moores University of California, San Diego (UCSD) Cancer Center, San Diego, CA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Biogen Idec.</itunes:summary>
      <itunes:subtitle>CLL Therapy: An Update from ASCO</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ccf701d7-f2de-281e-030d-cae13a2c02dd.mp3" type="audio/mpeg" length="14679481"/>
      <media:title>CLL Therapy: An Update from ASCO</media:title>
      <media:text type="plain">6/25/2008&#13;
&#13;
CLL Therapy: An Update from the American Society of Clinical Oncology&#13;
&#13;
This program featured Thomas J. Kipps, M.D., PhD, professor, Department of Medicine, Deputy Director of Research, Moores University of California, San Diego (UCSD) Cancer Center, San Diego, CA.&#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society and was supported by an unrestricted educational grant from Cephalon Oncology and Biogen Idec.</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ccf701d7-f2de-281e-030d-cae13a2c02dd.mp3" type="audio/mpeg" fileSize="14679481" duration="3670"/>
      <link>http://lls.hipcast.com/deluge/ccf701d7-f2de-281e-030d-cae13a2c02dd.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">71c40744-499c-af37-1ccb-1f1435aa6627</guid>
      <title>Stem Cell Transplantation: Current Trends/Future Directions</title>
      <description><![CDATA[2/21/2008

This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.

This program was sponsored by The Leukemia and Lymphoma Society.

Click here for the direct link to the audio:
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3]]></description>
      <pubDate>Mon, 05 May 2008 16:04:47 GMT</pubDate>
      <itunes:duration>00:58:44</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>2/21/2008&#13;
&#13;
This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.&#13;
&#13;
This program was sponsored by The Leukemia and Lymphoma Society.&#13;
&#13;
Click here for the direct link to the audio:&#13;
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</itunes:summary>
      <itunes:subtitle>Stem Cell Transplantation: Current Trends/Future Directions</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3" type="audio/mpeg" length="14097369"/>
      <media:title>Stem Cell Transplantation: Current Trends/Future Directions</media:title>
      <media:text type="plain">2/21/2008&#13;
&#13;
This program featured Armand Keating, MD, FRCP(C), Professor of Medicine, Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation at the University of Toronto.  Director, Cell Therapy Program at Princess Margaret Hospital/Ontario Cancer Institute in Toronto, Ontario, Canada.&#13;
&#13;
This program was sponsored by The Leukemia and Lymphoma Society.&#13;
&#13;
Click here for the direct link to the audio:&#13;
http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3" type="audio/mpeg" fileSize="14097369" duration="3524"/>
      <link>http://lls.hipcast.com/deluge/c940160b-5502-04f4-cb52-949b96782aaf.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">8d335d8f-d89c-398a-9f80-909d0850a912</guid>
      <title>Sexuality and Intimacy After Cancer</title>
      <description><![CDATA[3/11/2008

This program featured Sage Bolte, MSW, LCSW, OSW-C, Oncology Counselor, Breast Cancer Program, Life with Cancer® Inova Cancer Services in Fairfax, Virginia.

This program was supported by The Leukemia and Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3]]></description>
      <pubDate>Fri, 28 Mar 2008 16:59:57 GMT</pubDate>
      <itunes:duration>00:58:39</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>3/11/2008&#13;
&#13;
This program featured Sage Bolte, MSW, LCSW, OSW-C, Oncology Counselor, Breast Cancer Program, Life with Cancer® Inova Cancer Services in Fairfax, Virginia.&#13;
&#13;
This program was supported by The Leukemia and Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3</itunes:summary>
      <itunes:subtitle>Sexuality and Intimacy After Cancer</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3" type="audio/mpeg" length="14075426"/>
      <media:title>Sexuality and Intimacy After Cancer</media:title>
      <media:text type="plain">3/11/2008&#13;
&#13;
This program featured Sage Bolte, MSW, LCSW, OSW-C, Oncology Counselor, Breast Cancer Program, Life with Cancer® Inova Cancer Services in Fairfax, Virginia.&#13;
&#13;
This program was supported by The Leukemia and Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3" type="audio/mpeg" fileSize="14075426" duration="3519"/>
      <link>http://lls.hipcast.com/deluge/c8641f38-69d9-13d3-34c8-663ded82ead0.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">56a426a4-75b8-416f-f5d8-a7bf87d67360</guid>
      <title>Stem Cell Transplantation: Making an Informed Choice</title>
      <description><![CDATA[02/02/06

This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. 

This program was sponsored by The Leukemia & Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. 

Alternate link to the audio:
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:47:30 GMT</pubDate>
      <itunes:duration>00:51:01</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>02/02/06&#13;
&#13;
This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</itunes:summary>
      <itunes:subtitle>Stem Cell Transplantation: Making an Informed Choice</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3" type="audio/mpeg" length="12244226"/>
      <media:title>Stem Cell Transplantation: Making an Informed Choice</media:title>
      <media:text type="plain">02/02/06&#13;
&#13;
This free telephone education program took place on Thursday, Feb. 2, 2006. The program featured Armand Keating, M.D., professor and head, Department of Medical Oncology and Hematology Princess Margaret Hospital/Ontario Cancer Institute, Toronto, ON. &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society in collaboration with the National Marrow Donor Program and was supported through an educational grant from Amgen. &#13;
&#13;
Alternate link to the audio:&#13;
http://lls.audioblog.com/download/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3" type="audio/mpeg" fileSize="12244226" duration="3061"/>
      <link>http://lls.hipcast.com/deluge/ae0dbca9-5f01-41fc-611e-988904a27e65.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">aef48dbd-0625-72c3-7cc7-295be85215c0</guid>
      <title>New Perspectives on Stem Cell Transplantation</title>
      <description><![CDATA[06/21/07

This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.

Alternate link to the audio:
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:45:40 GMT</pubDate>
      <itunes:duration>00:53:40</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>06/21/07&#13;
&#13;
This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</itunes:summary>
      <itunes:subtitle>New Perspectives on Stem Cell Transplantation</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3" type="audio/mpeg" length="12880794"/>
      <media:title>New Perspectives on Stem Cell Transplantation</media:title>
      <media:text type="plain">06/21/07&#13;
&#13;
This program featured Rainer F. Storb, M.D., head, Transplantation Biology Program at the Fred Hutchinson Cancer Research Program in Seattle, WA.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3" type="audio/mpeg" fileSize="12880794" duration="3220"/>
      <link>http://lls.hipcast.com/deluge/f872eaf3-1682-a5f7-9569-935f7133162c.mp3</link>
    </item>
    <item>
      <guid isPermaLink="false">e1d9905c-7917-3d9a-5528-5842fb22b84d</guid>
      <title>Practical Tips for Managing Your Finances and Insurance 2</title>
      <description><![CDATA[11/28/07

Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&A Session

This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia & Lymphoma Society, White Plains, NY.  

This program was sponsored by The Leukemia & Lymphoma Society.

Alternate link to the audio:
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3]]></description>
      <pubDate>Tue, 26 Feb 2008 20:44:57 GMT</pubDate>
      <itunes:duration>00:23:15</itunes:duration>
      <itunes:author>The Leukemia &amp; Lymphoma Society</itunes:author>
      <itunes:summary>11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&amp;A Session&#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</itunes:summary>
      <itunes:subtitle>Practical Tips for Managing Your Finances and Insurance 2</itunes:subtitle>
      <itunes:explicit>no</itunes:explicit>
      <enclosure url="http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3" type="audio/mpeg" length="5581764"/>
      <media:title>Practical Tips for Managing Your Finances and Insurance 2</media:title>
      <media:text type="plain">11/28/07&#13;
&#13;
Cancer Survivorship: Practical Tips for Managing Your Financial and Insurance Issues - Part 2 Q&amp;A Session&#13;
&#13;
This program featured Beth Darnley, chief program officer, Patient Advocate Foundation, Newport News, Virginia and Anita Welborn, LMSW, director, Information Resource Center (IRC),  The Leukemia &amp; Lymphoma Society, White Plains, NY.  &#13;
&#13;
This program was sponsored by The Leukemia &amp; Lymphoma Society.&#13;
&#13;
Alternate link to the audio:&#13;
http://lls.hipcast.com/download/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</media:text>
      <media:content url="http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3" type="audio/mpeg" fileSize="5581764" duration="1395"/>
      <link>http://lls.hipcast.com/deluge/ad858520-9141-1dc0-83f9-d88f41c26ae8.mp3</link>
    </item>
  </channel>
</rss>
